Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Eledon Pharmaceuticals (ELDN) Return on Assets (2016 - 2026)

Eledon Pharmaceuticals filings provide 4 years of Return on Assets readings, the most recent being 0.01% for Q4 2017.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.01% in Q4 2017 year-over-year; TTM through Dec 2017 was 0.01%, a 0.0% change, with the full-year FY2017 number at 0.01%, down 1.0% from a year prior.
  • Return on Assets hit 0.01% in Q4 2017 for Eledon Pharmaceuticals, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2014 to a low of 0.01% in Q4 2016.
  • Median Return on Assets over the past 4 years was 0.01% (2017), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Assets: up 0bps in 2015, down 0bps in 2015.
  • Eledon Pharmaceuticals' Return on Assets stood at 0.0% in 2014, then plummeted by -185bps to 0.01% in 2015, then plummeted by -50bps to 0.01% in 2016, then surged by 36bps to 0.01% in 2017.
  • The last three reported values for Return on Assets were 0.01% (Q4 2017), 0.01% (Q3 2017), and 0.01% (Q2 2017) per Business Quant data.